All posts by: Michael Zand

About Michael Zand

Altered virus may expand patient recruitment in human gene therapy … – Science Daily

Continue reading

2017-06-13 NEWS

Altered virus may expand patient recruitment in human gene therapy …
Science Daily
For many patients, participating in gene therapy clinical trials isn’t an option because their immune system recognizes and fights the helpful virus used for …

and more »

Continue reading

2017-06-13 NEWS

MilliporeSigma’s Proxy-CRISPR Tech Aims to Increase Usability of Native CRISPR Proteins
GenomeWeb
NEW YORK (GenomeWeb) – The discovery of bacterial CRISPR systems has created a cottage industry of researchers and biotechnology companies hoping to use the genome-editing method to cure disease or create better medications for a variety of …

Continue reading

2017-06-13 NEWS

Curetoday.com

Myeloma Immunotherapy Trials Paused
Curetoday.com
Myeloma Immunotherapy Trials Paused. Merck will be pausing two trials testing Keytruda in patients with multiple myeloma. JASON HARRIS. PUBLISHED: JUNE 13, 2017. Be the first to discuss this article on CURE’s forum. >> Talk about this article with

and more »

Continue reading

2017-06-13 NEWS

Stem cells might not be a good option for your kid’s sports injury
Miami Herald
Over the last several years, we have seen a dramatic increase in interest in regenerative medicine, especially the use of PRP and mesenchymal stem cells to help athletes return to their sport after injury. Yet many patients and caregivers struggle to